These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 5780202

  • 1. Factor XIII in human plasma and platelets.
    McDonagh J, McDonagh RP, Delâge JM, Wagner RH.
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [Abstract] [Full Text] [Related]

  • 2. Plasma factor XIII and platelet factor XIII in hyperlipaemia.
    Cucuianu MP, Miloszewski K, Porutiu D, Losowsky MS.
    Thromb Haemost; 1976 Dec 31; 36(3):542-50. PubMed ID: 1037152
    [Abstract] [Full Text] [Related]

  • 3. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C, Reul V, Schnider TW, Degiacomi P, Metzner H, Korte WC.
    Anesth Analg; 2009 Oct 31; 109(4):1023-8. PubMed ID: 19762725
    [Abstract] [Full Text] [Related]

  • 4. An acquired inhibitor to factor XIII.
    McDevitt NB, McDonagh J, Taylor HL, Roberts HR.
    Arch Intern Med; 1972 Nov 31; 130(5):772-7. PubMed ID: 5083419
    [No Abstract] [Full Text] [Related]

  • 5. Congenital hemorrhagic diathesis with deficiency of factor XIII. A case report and a family study.
    Abels J, Sibinga CT, Meyler L.
    Thromb Diath Haemorrh; 1970 May 31; 23(2):340-6. PubMed ID: 5426214
    [No Abstract] [Full Text] [Related]

  • 6. Investigations of the lupus-like inhibitor by-passing activity of platelets.
    Howard MA, Firkin BG.
    Thromb Haemost; 1983 Dec 30; 50(4):775-9. PubMed ID: 6420922
    [Abstract] [Full Text] [Related]

  • 7. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T, Fries D, Velik-Salchner C, Reif C, Klingler A, Innerhofer P.
    Anesth Analg; 2008 May 30; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [Abstract] [Full Text] [Related]

  • 8. ROTEM analysis: a significant advance in the field of rotational thrombelastography.
    Franz RC.
    S Afr J Surg; 2009 Feb 30; 47(1):2-6. PubMed ID: 19405329
    [Abstract] [Full Text] [Related]

  • 9. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G, Franceschini F, Guerra S, Meduri P, Scagliarini F.
    Quad Sclavo Diagn; 1973 Mar 30; 9(1):497-581. PubMed ID: 4210088
    [No Abstract] [Full Text] [Related]

  • 10. Immunological studies of coagulation factor XIII.
    Israels ED, Paraskevas F, Israels LG.
    J Clin Invest; 1973 Oct 30; 52(10):2398-403. PubMed ID: 4199604
    [Abstract] [Full Text] [Related]

  • 11. Ex vivo coagulation test on tissue factor-expressing cells with a calibrated automated thrombogram.
    Takamiya O, Sakata M.
    Lab Hematol; 2008 Oct 30; 14(4):39-44. PubMed ID: 19095614
    [Abstract] [Full Text] [Related]

  • 12. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG, Cohen BM, Cohen E.
    Acta Anaesthesiol Scand; 2005 Feb 30; 49(2):222-31. PubMed ID: 15715625
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.
    Lorand L, Urayama T, De Kiewiet JW, Nossel HL.
    J Clin Invest; 1969 Jun 30; 48(6):1054-64. PubMed ID: 4977030
    [Abstract] [Full Text] [Related]

  • 14. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L, Polgár J, Boda Z.
    Thromb Haemost; 1993 Mar 01; 69(3):282-5. PubMed ID: 8097064
    [Abstract] [Full Text] [Related]

  • 15. [Data on coagulation factor 13 (FSF)].
    Ströder J, Rath W.
    Klin Padiatr; 1972 Jan 01; 184(1):4-8. PubMed ID: 4554372
    [No Abstract] [Full Text] [Related]

  • 16. Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM).
    Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM.
    Eur J Cardiothorac Surg; 2007 Jun 01; 31(6):1052-7. PubMed ID: 17398108
    [Abstract] [Full Text] [Related]

  • 17. Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI.
    Lipscomb MS, Walsh PN.
    J Clin Invest; 1979 May 01; 63(5):1006-14. PubMed ID: 447822
    [Abstract] [Full Text] [Related]

  • 18. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F, Fiedler K, von Depka M, Luedde T, Hecker H, Manns MP, Ganser A, Trautwein C.
    Liver Int; 2006 Mar 01; 26(2):173-81. PubMed ID: 16448455
    [Abstract] [Full Text] [Related]

  • 19. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait.
    Okonkwo P, Post R, Sise H.
    Thromb Diath Haemorrh; 1970 Jun 30; 23(3):423-31. PubMed ID: 5432187
    [No Abstract] [Full Text] [Related]

  • 20. Human platelet fibrinogen: a protein different from plasma fibrinogen.
    Soria J, Soria C, Samama M, Poirot E, Kling C.
    Pathol Biol (Paris); 1976 Dec 30; 24 Suppl():15-7. PubMed ID: 796805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.